164 related articles for article (PubMed ID: 7803900)
21. Acute lymphoblastic leukemia associated with a t(1;19)(q23;p13) in an adult.
Ohno H; Inoue T; Akasaka T; Okumura A; Miyanishi S; Ohashi I; Kikuchi M; Masuya M; Amano H; Imanaka T
Intern Med; 1993 Jul; 32(7):584-7. PubMed ID: 8286840
[TBL] [Abstract][Full Text] [Related]
22. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
23. The biology and treatment of acute lymphoblastic leukemia in adults.
Copelan EA; McGuire EA
Blood; 1995 Mar; 85(5):1151-68. PubMed ID: 7858247
[TBL] [Abstract][Full Text] [Related]
24. Double marker analysis for terminal deoxynucleotidyl transferase and myeloid antigens in acute nonlymphocytic leukemia patients and healthy subjects.
Adriaansen HJ; Hooijkaas H; Kappers-Klunne MC; Hählen K; van't Veer MB; van Dongen JJ
Haematol Blood Transfus; 1990; 33():41-9. PubMed ID: 2323649
[No Abstract] [Full Text] [Related]
25. Gene rearrangements in T-cell lymphoblastic lymphoma.
Pilozzi E; Müller-Hermelink HK; Falini B; de Wolf-Peeters C; Fidler C; Gatter K; Wainscoat J
J Pathol; 1999 Jul; 188(3):267-70. PubMed ID: 10419594
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin.
Basso G; Putti MC; Catoretti G; Consolini R; Galdiolo D; Guglielmi C; Messina C; Milanesi C; Testi AM; Xillo MZ
Eur J Haematol; 1987 Feb; 38(2):111-6. PubMed ID: 3036570
[TBL] [Abstract][Full Text] [Related]
27. The immunophenotype of adult T acute lymphoblastic leukemia in Morocco.
Lahjouji A; Bachir F; Bennani S; Quessar A; Amzazi S
Exp Oncol; 2015 Mar; 37(1):64-9. PubMed ID: 25804235
[TBL] [Abstract][Full Text] [Related]
28. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
29. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
[TBL] [Abstract][Full Text] [Related]
30. Expression of myeloid antigens in acute lymphoblastic leukaemia.
Howard MR; Reid MM
Br J Haematol; 1994 Dec; 88(4):897-8. PubMed ID: 7819119
[No Abstract] [Full Text] [Related]
31. Association of GP40/CD7+ acute myeloblastic leukemia and chromosome 5 aberrations.
Lutz D; Kasparu H; Nowotny H; Weber E; Krieger O; Köller U; Tüchler H; Knapp W
Haematol Blood Transfus; 1990; 33():141-4. PubMed ID: 1691128
[No Abstract] [Full Text] [Related]
32. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
Tang YM
Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
[TBL] [Abstract][Full Text] [Related]
33. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
[TBL] [Abstract][Full Text] [Related]
34. Terminal deoxynucleotidyl transferase and HLA-DR expression appear unrelated to prognosis of acute myeloid leukaemia.
Swirsky DM; Greaves MF; Gray RG; Rees JK
Br J Haematol; 1988 Oct; 70(2):193-8. PubMed ID: 2973345
[TBL] [Abstract][Full Text] [Related]
35. Surface immunoglobulin-negative acute lymphoblastic leukaemia with predominant L1 morphology, occasional L3 cells and t(8;22).
Reid MM; Drewery C; Windebank KP
Br J Haematol; 2003 Sep; 122(5):693. PubMed ID: 12930379
[No Abstract] [Full Text] [Related]
36. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
[No Abstract] [Full Text] [Related]
37. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
38. [Cell origin of 18 patients with non-T, non-B acute lymphoblastic leukemia].
Tang MH
Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):345-7. PubMed ID: 2482806
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
40. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement.
Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M
Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
